期刊文献+

呼吸机相关性肺炎的临床分析 被引量:20

Ventilator-associated Pneumonia: 65 Cases Report
暂未订购
导出
摘要 目的:研究呼吸机相关性肺炎(VAP)的发病率、病死率、危险因素及病原菌分布,探讨预防措施。方法:对65例机械通气患者的临床资料进行回顾性分析。结果:本组VAP的发生率为43.08%,病死率为46.43%。VAP的发生与年龄、机械通气时间、鼻饲、抑酸剂及抗生素的应用有关。共检出病原菌54株,其中革兰阴性菌45株,占83.33%,前三位致病菌依次为铜绿假单胞菌、嗜麦芽窄食单胞菌和木糖氧化产碱杆菌;革兰阳性菌4株,占7.41%;真菌5株,占9.26%。结论:危险因素的存在与VAP的发生密切相关。主要致病菌为铜绿假单胞菌和嗜麦芽窄食单胞菌。 Objective: To study the morbility, mortality, risk factors and pathogen of ventilator-associated pneumonia (VAP) for the decision of the prevention strategies. Methods: The clinical data of 65 patients received mechanical ventilation were retrospectively analyzed. Results: The morbidity and mortality of VAP were 43.08% and 46.43%. Age, period of mechanical ventilator, nasogastric feeding, use of antiacid and antibiotics were related to the development with VAP. Fifty- four strains of pathogens were isolated from 28 cases with VAP, the percentages of Gram-negative bacilli, Gram-positive cocci and fungi were 83.33%, 7.41% and 9. 26% respectively. Pseudomonas aeruginosa, Stenotrophornonas rnaltophilia and Achrornobacter xylosoxidans were the most common pathogens. Conclusion: The presence of risk factors is correlated with VAP. The main pathogens are Pseudornonas aeruginosa and X. Maltophilia.
出处 《武汉大学学报(医学版)》 CAS 2006年第3期412-414,共3页 Medical Journal of Wuhan University
关键词 呼吸机相关性肺炎 相关危险因素 病原体 Ventilator-Associated Pneumonia High Risk Factors Pathogen
  • 相关文献

参考文献9

二级参考文献35

  • 1覃涛,刘卫.弥漫性泛细支气管炎及其治疗进展[J].中国医学文摘(内科学),2005,26(5):613-615. 被引量:8
  • 2刘凤谊,王全凤.填充墙对结构刚度的影响[J].山西建筑,2007,33(9):93-94. 被引量:9
  • 3Perry C, Chendrasekhar A, Moorman DW, et al. Ventilator associated pneumonia:therapy based protected specimen brushing versus trachea aspirate data. Chest, 1999,116 (4) :278 S-281 S.
  • 4JRS. The Japanese Respiratory Society guidelines for management of hospital-acquired pneumonia. Respir,2004,9 ( 9 ): S30-S34.
  • 5Gruson D, Hilbert G,Vargas F, et al. Strategy of antibiotic rotation:longterm effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia. Crit Care Med, 2003,31(7) :1908-1914.
  • 6Raymond DP, Pelletier SJ, Crabtree TD, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit.Crit Care Med,2001,29(6) :1101-1108.
  • 7Kollef M. Appropriate empirical antibacterial therapy for nosocomial infections:getting it right the first time. Drugs, 2003,63 (20):2157-2168.
  • 8Masterton R, Drusano G, Paterson DL, et al. Appropriate antimicrobial treatment in nosocomial infections-the clinical challenges. J Hosp Infeet,2003,55 ( Suppl 1 ): 1-12.
  • 9Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults:a randomized trial. JAMA ,2003,290(19) :2588-2598.
  • 10Dennesen PJ ,van der Ven AJ, Kessels AG, et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilatorassociated pneumonia. Am J Respir Crit Care Med, 2001,163 ( 6 ):1371-1375.

共引文献1086

同被引文献165

引证文献20

二级引证文献191

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部